Guanfacine News

Shire Announces NDA Submission of Guanfacine Extended - Release for the Treatment of ADHD in Children and Adolescents

Basingstoke, UK and Philadelphia, US – August 24, 2006 – Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for its...